Evidence map›Paper›PMID 40064625›Full record

ArticleThe International journal of health planning and management2025

Establishing Sustainable Access to Quality Uterotonics in Kano, Lagos and Niger States-A Supply Chain Perspective.

Eba Ajima, Chukwunonso Nwaokorie, Naanma Kangkum, Lola Ameyan, Obruche Sophia Ogefere, Eric Aigbogun, Valentine Amasiatu, Uchenna Igbokwe

Abstract read
In one paragraph

Article in The International journal of health planning and management, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eba AjimaSolina Centre for International Development and Research (SCIDaR), Abuja, Nigeria.
Chukwunonso NwaokorieSolina Centre for International Development and Research (SCIDaR), Abuja, Nigeria.
Naanma KangkumSolina Centre for International Development and Research (SCIDaR), Abuja, Nigeria.
Lola AmeyanClinton Health Access Initiative (CHAI), Boston, Massachusetts, USA.
Obruche Sophia OgefereSolina Centre for International Development and Research (SCIDaR), Abuja, Nigeria.
Eric AigbogunSolina Centre for International Development and Research (SCIDaR), Abuja, Nigeria.ORCID 0000-0001-8230-2771
Valentine AmasiatuSolina Centre for International Development and Research (SCIDaR), Abuja, Nigeria.ORCID 0000-0003-4185-2237
Uchenna IgbokweSolina Centre for International Development and Research (SCIDaR), Abuja, Nigeria.

Funding

Merck Sharp and Dohme
6 · The paper itself

Abstract

backgroundThe quality of oxytocin and misoprostol, the most widely used uterotonics for postpartum haemorrhage (PPH) management, suffer supply chain challenges and climactic susceptibilities.

aimTo describe a supply chain strengthening programme for introducing heat-stable Carbetocin (HSC), to health facilities in Kano, Lagos and Niger states.

methodHuman-centred design (HCD) was employed to uncover uterotonics supply chain challenges and to identify priority interventions across a market-shaping value chain to facilitate the rollout of HSC. Through a mixed-methods approach and interviews with 203 stakeholders, challenges in the uterotonics supply chain and potential solutions were identified. A market-shaping value chain was employed to map HSC introduction and rollout, focusing on key interventions. Before the project initiation, we established clear objectives including identifying barriers, introduction and rollout journey mapping of HSC.

resultsUsing HCD, HSC was successfully rolled out to over 87 health facilities. Employing the market-shaping value chain, pivotal interventions were executed. These included policy updates (inclusion of HSC in the National and States Essential Medicines List), regulatory actions (registering Carbetocin with NAFDAC), financing strategies (co-developing state roadmaps for sustainable procurements), supply management (reducing stock-outs) and healthcare provider training on supply chain management practices. These efforts facilitated seamless integration of HSC into the states' supply chains.

conclusionHCD and market-shaping value chain approach were employed to introduce HSC in Nigeria. This study shows that integrating these approaches can enhance the availability and accessibility of essential medicines, offering potential replicability in similar health systems.

Indexed as

Health Services AccessibilityMisoprostolOxytocicsOxytocinFemaleHumansInterviews as TopicNigerNigeriaPostpartum HemorrhagePregnancyMisoprostolOxytocicsOxytocinheat‐stable Carbetocinhuman‐centred designmarket‐shapingpostpartum haemorrhage

Identifiers

PMID40064625
PMCPMC12045771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.